ClearCorrect, Inc., expands

November 2009
Proofs;Nov2009, Vol. 92 Issue 5, p84
Trade Publication
The article reports on the completion of the headquarters expansion of ClearCorrect Inc. in Houston, Texas in November 2009. The expansion was reportedly in response to the increased market demand for its Food and Drug Administration (FDA)-cleared transparent orthodontic aligners. With the facility expansion, the company can increase its production of the aligners by 600% and its staff by 30%, says chief executive officer (CEO) Dr. Willis Pumphrey.


Related Articles

  • Court report.  // Medical Device Daily;2/19/2009, Vol. 13 Issue 32, p4 

    The article reports that Align Technology in Santa Clara, California, has been notified of a purported declaratory judgment action filed against the company by ClearCorrect in Houston, Texas, at the U.S. District Court for the Southern District of Texas on February 17, 2009. An overview of the...

  • OptiMedica Expands Operations with Move to New Global Headquarters.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article informs that OptiMedica Corp. has expanded its operation size to 55,000 square foot facility for global headquarters at Sunnyvale, California. All business function of the company will be housed in the new headquarters including commercial launch of the Catalyst Precision Laser...

  • CDER Office Building 1.  // Buildings;Oct2006, Vol. 100 Issue 10, p74 

    This article states that the CDER Office Building 1, the second phase of construction in the U.S. Food and Drug Administration's consolidation into the Federal Research Center, is the largest building in the complex. The LEED Silver design consists of a 6-story, H-shaped structure and a 4-story,...

  • NEWS WIRE.  // Dairy Field;Jan2004, Vol. 187 Issue 1, p8 

    Presents updates related to dairy industry in the U.S. as of January 2004. Appointment of Connie Tipton as president of the International Dairy Foods Association; Plan of Wells' Dairy Inc. to build a new corporate headquarters; Issuance of an advisory regarding the safety of milk from animals...

  • Northfield Labs, Xtent report plans to dissolve companies.  // Medical Device Daily;5/19/2009, Vol. 13 Issue 95, p10 

    This article reveals the plan of Northfield Laboratories to shut down its business operations and conduct an orderly disposition of its assets. A review and analysis of the complete response letter received from the U.S. Food and Drug Administration prompted the decision. All employees at its...

  • Pulse.  // ENR: Engineering News-Record;4/7/2008, Vol. 260 Issue 12, p68 

    This section offers news briefs related to the construction industry. STV/Ralph Whitehead Associates has been awarded a contract valued at up to $30 million by the Charlotte City Council to provide planning, environmental and engineering services for the Lynx Blue Line extension. Panda Energy...

  • FDA identifies more problems at Invacare. SODER, CHUCK // Crain's Cleveland Business;1/25/2016, Vol. 37 Issue 4, p0006 

    The article discusses the alleged poor quality control system of medical equipment company Invacare Corp. according to the U.S. Food and Drug Administration (FDA). Topics covered include the highlights of a report released by the FDA after investigating Invacare's headquarters located in Elyria,...

  • On the Beat.  // Cotton Grower;May2013, Vol. 49 Issue 5, p4 

    This section offers news briefs concerning the U.S. cotton industry as of May 2013. Topics covered include the official opening of a research and development (R&D) facility at the headquarters of Dow AgroScience in Indianapolis, Indiana, on April 10, the amount invested by Helena Chemical Co. in...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics